Trials / Active Not Recruiting
Active Not RecruitingNCT03196518
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
PET Imaging of Thyroid Tissue Expressing Sodium-iodine Symporter Using the New Tracer 18F-tetrafluoroborate (18F-TFB)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and that does not interfere with the uptake of radioactive iodine used for therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET Imaging | PET/CT study immediately after injection |
| OTHER | 18F-tetrafluoroborate (18F-TFB) | administration of a single dose of approximately 5-10 mCi 18F-TFB (mass \<= 50 μg) for imaging purposes |
Timeline
- Start date
- 2017-06-16
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2017-06-22
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03196518. Inclusion in this directory is not an endorsement.